HCID 67958162, compound → HCID 71603517, compound

HRID 2278325Notes

Reaction equation

HRID 2278325 reaction equation
[N+:1]([C:4]1[CH:5]=[N:6][C:7]([O:10][C:11]2[C:16]3[C:17]([CH3:21])([CH3:20])[CH2:18][O:19][C:15]=3[C:14]([CH3:22])=[CH:13][CH:12]=2)=[N:8][CH:9]=1)([O-])=O>C1COCC1.[Pd]>[CH3:20][C:17]1([CH3:21])[C:16]2[C:11]([O:10][C:7]3[N:6]=[CH:5][C:4]([NH2:1])=[CH:9][N:8]=3)=[CH:12][CH:13]=[C:14]([CH3:22])[C:15]=2[O:19][CH2:18]1

Participants

4

Procedure

5-nitro-2-[(3,3,7-trimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]pyrimidine (Intermediate 32, 243 mg, 0.81 mmol) was dissolved in THF (4 mL) and Palladium on charcoal (5 mol %, 85 mg) was added. The reaction mixture was stirred under hydrogen atmosphere (3 bar) for 1 hour at room temperature. The catalyst was filtered on a pad of celite, washed with THF and the resulting solution was concentrated under vacuum. The residue was diluted with ethyl acetate and water, the organic phase collected, dried over Na2SO4 and evaporated to afford the title compound (220 mg) as colorless oil. The crude product, was used in the next step without further purification.

Workup

  1. filtrationThe catalyst was filtered on a pad of celite
  2. washwashed with THF
  3. concentrationthe resulting solution was concentrated under vacuum
  4. additionThe residue was diluted with ethyl acetate and water
  5. customthe organic phase collected
  6. dry with materialdried over Na2SO4
  7. customevaporated

Sources & evidence

ORD record
ord-2c55c904d0624cc281820c3a54becca4
Source dataset
uspto-grants-2015_09
Patent number
US09133175B2

Reaction notes

Loading…